References
- Barber ED, Hill T, Schum DB. (1995). The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro. Toxicol Lett 80:167–72
- Boatman RJ, English JC, Perry LG, Bialecki VE. (1996). Differences in the nephrotoxicity of hydroquinone among Fischer 344 and Sprague-Dawley rats and B6C3F1 mice. J Toxicol Environ Health 47:159–72
- Boatman RJ, English JC, Perry LG, Fiorica LA. (2000). Covalent protein adducts of hydroquinone in tissues from rats: quantitation of sulfhydryl-bound forms following single gavage or intraperitoneal administration or repetitive gavage administration. Chem Res Toxicol 13:861–72
- David RM, English JC, Totman LC, et al. (1998). Lack of nephrotoxicity and renal cell proliferation following subchronic dermal application of a hydroquinone cream. Food Chem Toxicol 36:609–16
- Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
- DeCaprio AP. (1999). The toxicology of hydroquinone-relevance to occupational and environmental exposure. Crit Rev Toxicol 29:283–330
- Deisinger PJ, English JC. (1999). Bioavailability and metabolism of hydroquinone after intratracheal instillation in male rats. Drug Metab Dispos 27:442–8
- Divincenzo GD, Hamilton ML, Reynolds RC, Ziegler DA. (1984). Metabolic fate and disposition of [14C]hydroquinone given orally to Sprague-Dawley rats. Toxicology 33:9–18
- English JC, Deisinger PJ. (2005). Metabolism and disposition of hydroquinone in Fischer 344 rats after oral or dermal administration. Food Chem Toxicol 43:483–93
- Galloway S, Armstrong M, Reuben C, et al. (1987). Chromosome aberration and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10:1–176
- Glockl I, Blaschke G, Vei M. (2001). Validated methods for direct determination of hydroquinone glucuronide and sulfate in human urine after oral intake of bearberry leaf extract by capillary zone electrophoresis. J Chromatogr B Biomed Sci Appl 761:261–6
- Gocke E, King MT, Eckardt K, Wild D. (1981). Mutagenicity of cosmetic ingredients licensed by the European communities. Mutat Res 90:91–109
- Hazardous Substances Databank (HSDB). (2015). Hydroquinone; National Library of Medicine Toxnet System: Record No. 123-31-9. Hazardous Substances Databank. Available at: http://www.toxnet.nlm.nih.gov [last accessed 6 Jan 2017]
- Kostiainen R, Kotiaho T, Kuuranne T, Auriola S. (2003). Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. J Mass Spectrom 38:357–72
- Levay G, Pongracz K, Bodell WJ. (1991). Detection of DNA adducts in hl-60 cells treated with hydroquinone and p-benzoquinone by p-postlabeling. Carcinogenesis 12:1181–6
- Nakamura M, Yamazaki I, Kotani T, Ohtaki S. (1985). Thyroid peroxidase selects the mechanism of either 1- or 2-electron oxidation of phenols, depending on their substituents. J Biol Chem 260:13546–52
- National Research Council. (2011). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press
- NTP. (1989). Toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9)in F344/N rats and B6C3F1 mice (Gavage Studies), TR 366. Natl Toxicol Program Tech Rep Ser 366:1–248
- Topping DC, Bernard LG, O’donoghue JL, English JC. (2007). Hydroquinone: acute and subchronic toxicity studies with emphasis on neurobehavioral and nephrotoxic effects. Food Chem Toxicol 45:70–8
- Tunek A, Högstedt B, Olofsson T. (1982). Mechanism of benzene toxicity. Effects of benzene and benzene metabolites on bone marrow cellularity, number of granulopoietic stem cells and frequency of micronuclei in mice. Chem Biol Interact 39:129–38
- Westerhof W, Kooyers TJ. (2005). Hydroquinone and its analogues in dermatology - a potential health risk. J Cosmet Dermatol 4:55–9
- Yáñez JA, Remsberg CM, Sayre CL, et al. (2011). Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv 2:643–72